Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
AMGEN Inc (NASDAQ: AMGN) closed the day trading at $328.97 up 1.44% from the previous closing price of $324.3. In other words, the price has increased by $1.44 from its previous closing price. On the day, 1.9 million shares were traded. AMGN stock price reached its highest trading level at $329.2 during the session, while it also had its lowest trading level at $323.55.
Ratios:
For a better understanding of AMGN, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 18.76 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.35. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 1.28. In the meantime, Its Debt-to-Equity ratio is 5.67 whereas as Long-Term Debt/Eq ratio is at 5.45.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 20 ’25 when Grygiel Nancy A. sold 3,139 shares for $337.26 per share. The transaction valued at 1,058,667 led to the insider holds 7,225 shares of the business.
Grygiel Nancy A. bought 3,139 shares of AMGN for $1,058,667 on Nov 20 ’25. On Nov 12 ’25, another insider, Khosla Rachna, who serves as the SVP, Business Development of the company, sold 890 shares for $336.24 each. As a result, the insider received 299,256 and left with 7,082 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMGN now has a Market Capitalization of 177143971840 and an Enterprise Value of 222285987840. As of this moment, AMGEN’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.43, and their Forward P/E ratio for the next fiscal year is 14.94. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.06. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.94 while its Price-to-Book (P/B) ratio in mrq is 18.42. Its current Enterprise Value per Revenue stands at 6.18 whereas that against EBITDA is 13.487.
Stock Price History:
The Beta on a monthly basis for AMGN is 0.46, which has changed by 0.20365214 over the last 52 weeks, in comparison to a change of 0.17287207 over the same period for the S&P500. Over the past 52 weeks, AMGN has reached a high of $346.38, while it has fallen to a 52-week low of $261.43. The 50-Day Moving Average of the stock is -0.10%, while the 200-Day Moving Average is calculated to be 10.22%.
Shares Statistics:
Over the past 3-months, AMGN traded about 2.70M shares per day on average, while over the past 10 days, AMGN traded about 2256380 shares per day. A total of 538.50M shares are outstanding, with a floating share count of 537.46M. Insiders hold about 0.19% of the company’s shares, while institutions hold 81.17% stake in the company. Shares short for AMGN as of 1767139200 were 14978144 with a Short Ratio of 5.55, compared to 1764288000 on 14322050. Therefore, it implies a Short% of Shares Outstanding of 14978144 and a Short% of Float of 2.79.
Dividends & Splits
AMGN’s forward annual dividend rate is 9.52, up from 9.39 a year ago. Against a Trailing Annual Dividend Yield of 0.028954674. The stock’s 5-year Average Dividend Yield is 3.07. The current Payout Ratio is 119.05% for AMGN, which recently paid a dividend on 2025-11-21 with an ex-dividend date of 2026-02-13. Stock splits for the company last occurred on 1999-11-22 when the company split stock in a 2:1 ratio.
Earnings Estimates
The stock of AMGEN Inc (AMGN) is currently in the spotlight, with 23.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is $5.14, with high estimates of $6.55 and low estimates of $4.49.
Analysts are recommending an EPS of between $22.3 and $20.6 for the fiscal current year, implying an average EPS of $21.26. EPS for the following year is $22.03, with 29.0 analysts recommending between $24.49 and $20.33.
Revenue Estimates
21 analysts predict $9.45B in revenue. The current quarter. It ranges from a high estimate of $9.87B to a low estimate of $8.98B. As of. The current estimate, AMGEN Inc’s year-ago sales were $9.09BFor the next quarter, 21 analysts are estimating revenue of $8.63B. There is a high estimate of $8.97B for the next quarter, whereas the lowest estimate is $8.22B.
A total of 29 analysts have provided revenue estimates for AMGN’s current fiscal year. The highest revenue estimate was $36.76B, while the lowest revenue estimate was $35.87B, resulting in an average revenue estimate of $36.32B. In the same quarter a year ago, actual revenue was $33.42BBased on 29 analysts’ estimates, the company’s revenue will be $36.93B in the next fiscal year. The high estimate is $38.27B and the low estimate is $35.3B.
